These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14031846)

  • 1. Problems relating to investigational drugs.
    KELSEY FO
    J New Drugs; 1963; 3():71-4. PubMed ID: 14031846
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of investigational drugs in hospitals; a survey. I.
    TEPLITSKY B
    Hosp Prog; 1956 Aug; 37(8):76-82. PubMed ID: 13345319
    [No Abstract]   [Full Text] [Related]  

  • 3. PROGRESS ON INVESTIGATIONAL DRUGS.
    RANKIN WB
    SD J Med Pharm; 1964 Mar; 17():42-5. PubMed ID: 14126560
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of investigational drugs in hospitals; a survey. II.
    TEPLITSKY B
    Hosp Prog; 1956 Sep; 37(9):106; passim. PubMed ID: 13357155
    [No Abstract]   [Full Text] [Related]  

  • 5. Liability in use of investigational drugs.
    SCHREINER GE
    JAMA; 1963 Jul; 185():259-63. PubMed ID: 13987033
    [No Abstract]   [Full Text] [Related]  

  • 6. CONTROL EXPERIENCE WITH INVESTIGATIONAL NEW DRUGS.
    MEYERS EL
    Bull Parenter Drug Assoc; 1963; 17():27-37. PubMed ID: 14083963
    [No Abstract]   [Full Text] [Related]  

  • 7. The food and Drug Administration's view of investigational drugs.
    MEYERS EL
    SD J Med Pharm; 1963 Jul; 16():40-6. PubMed ID: 13935340
    [No Abstract]   [Full Text] [Related]  

  • 8. THE INVESTIGATIONAL DRUG BRANCH: A REVIEW OF OBJECTIVES AND FUNCTION.
    KELSEY FO
    J New Drugs; 1963; 3(4):250-5. PubMed ID: 14063363
    [No Abstract]   [Full Text] [Related]  

  • 9. Proving ground for tomorrow's drugs.
    HUNT MM; WOLTERS D
    Sci Illus; 1948 Aug; 3(8):17-23. PubMed ID: 18880995
    [No Abstract]   [Full Text] [Related]  

  • 10. INVESTIGATIONAL DRUG REGULATIONS AND CLINICAL RESEARCH.
    GIBSON ML
    J Oral Ther Pharmacol; 1964 Jul; 1():93-8. PubMed ID: 14204421
    [No Abstract]   [Full Text] [Related]  

  • 11. Problems relating to investigational drugs.
    KELSEY FO
    Am J Pharm Sci Support Public Health; 1963 Mar; 135():93-7. PubMed ID: 14031845
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ethical hazards in the search for new drugs].
    Godfraind MT
    Bull Mem Acad R Med Belg; 1993; 148(11 Pt 2):40-8. PubMed ID: 7987281
    [No Abstract]   [Full Text] [Related]  

  • 13. Problems relating to investigational drugs.
    Kelsey O
    Pharmakotherapia; 1964; 2(1):208-12. PubMed ID: 5875715
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug innovation on the decline.
    Young D
    Am J Health Syst Pharm; 2007 Feb; 64(3):228, 231. PubMed ID: 17244865
    [No Abstract]   [Full Text] [Related]  

  • 15. NME digest.
    Drug News Perspect; 2007; 20(6):395-402. PubMed ID: 18019747
    [No Abstract]   [Full Text] [Related]  

  • 16. Early access to new medicines.
    Breckenridge A; Walley T
    Clin Pharmacol Ther; 2008 Jul; 84(1):23-5. PubMed ID: 18288079
    [No Abstract]   [Full Text] [Related]  

  • 17. Substances doubtful for bulk drug substances list could be INDs.
    Thompson CA
    Am J Health Syst Pharm; 2016 Apr; 73(8):512-4. PubMed ID: 27045058
    [No Abstract]   [Full Text] [Related]  

  • 18. Biosimilars: considerations for an abbreviated pathway.
    Kozlowski S; Behrman R
    Leuk Lymphoma; 2009 Apr; 50(4):527-8. PubMed ID: 19373649
    [No Abstract]   [Full Text] [Related]  

  • 19. Biosimilars and safety issues.
    Dammacco F; Abbracchio MP; Gesualdo L; Goffredo F; Ronco C; Zanella A
    Leuk Lymphoma; 2009 Apr; 50(4):656-8. PubMed ID: 19373667
    [No Abstract]   [Full Text] [Related]  

  • 20. Beware of new drugs, study suggests.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 May; 13(10):1-2, 5. PubMed ID: 12492085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.